ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

China's Sinovac booster shot is 94 pc efficient against Omicron, claims company

Beijing [China], December 17 (ANI): China's biotech firm Sinovac claimed that a third dose of its COVID-19 vaccine is 94 per cent effective against the Omicron variant of the COVID-19.

ANI Dec 17, 2021 07:06 IST googleads

Representative image

Beijing [China], December 17 (ANI): China's biotech firm Sinovac claimed that a third dose of its COVID-19 vaccine is 94 per cent effective against the Omicron variant of the COVID-19.
This comes a day after a study found that the two doses of the vaccine failed to generate any detectable antibody response against the fast-spreading variant.
The study was conducted by the company on 20 people who received two shots and another 48 who received three shots. Seven in the first group and 45 in the second tested positive in neutralizing antibodies against the Omicron variant, the company said in a statement to the Global Times.
Sinovac said that the data demonstrated that the administration of a booster shot of its vaccine can effectively enhance the vaccine's neutralizing capacity to the Omicron variant, read the statement.
The company's findings are in contrast with those released on Tuesday in a preprint paper by the HKU researchers.
The university study also examined neutralising antibodies, one arm of immune response that serves as a rough marker for protection against infection.
Of 25 people who received a full two-dose course of CoronaVac, none were found to have detectable levels of neutralising antibodies, according to study author and top infectious disease expert Yuen Kwok-yung and his team.
The Omicron variant, first discovered in early November, has been reported in 77 countries and regions, according to the World Health Organization. (ANI)

Get the App

What to Read Next

Asia

China’s expanding system of censorship exposed in Dharamshala

China’s expanding system of censorship exposed in Dharamshala

The event titled "Understanding China's System of Political Repression: Voices of Resistance through Art and Journalism" brought together prominent voices critical of China's information control, as reported by Phayul.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Asia

Tibetan Women’s Association organises protest against China

Tibetan Women’s Association organises protest against China

It's an event to remember the day when Tibetan women from all three provinces of Tibet, for the first time in the history of Tibet, stood together and raised their voice against the brutal Chinese military forces that were occupying Tibet in 1959.

Read More
Asia

India’s Consul General meets Ant Group to boost tech ties

India’s Consul General meets Ant Group to boost tech ties

India's Consul General in Shanghai, Pratik Mathur, met Ant Group leadership to discuss fintech and digital economy opportunities. This follows high-level engagements with Shanghai's Mayor, aligned with Prime Minister Narendra Modi's "Reform, Perform and Transform" mantra to strengthen bilateral and multilateral cooperation through the SCO and BRICS.

Read More
US

UNSC adopts resolution condemning Iran’s “egregious attacks”

UNSC adopts resolution condemning Iran’s “egregious attacks”

The UN Security Council has adopted a resolution condemning Iran's "egregious attacks" against regional neighbours, demanding an immediate halt to hostilities and interference with maritime trade. While 13 members voted in favour, Russia and China abstained, with Tehran dismissing the move as a "manifest injustice" and a "serious setback."

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.